&nbsp;

Nov 2025

Regimen

ALEC

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

Exceptional Access Program

alectinib - Treatment of ALK-positive locally advanced or metastatic non-small cell lung cancer, according to specific criteria

Drugs Used:

alectinib

Quick Link(s):

Regimen Monograph

Regimen

ASCI

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

asciminib - For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, based on criteria

Drugs Used:

asciminib

Quick Link(s):

Regimen Monograph

Drug

acalabrutinib

Other Name(s): Calquence®

Quick Link(s):

Dec 1969

Drug

abemaciclib

Other Name(s): Verzenio®

Quick Link(s):

Oct 2025

Drug

anastrozole

Other Name(s): Arimidex®

Quick Link(s):

Dec 1969

Regimen

ACAL

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

acalabrutinib - For the treatment of adult patients with chronic lymphocytic leukemia (CLL), based on criteria

Drugs Used:

acalabrutinib

Quick Link(s):

Regimen Monograph

Drug

atezolizumab

Other Name(s): Tecentriq™

Quick Link(s):

Dec 1969

Guidelines and Advice

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline

Status: Current
ID: GL 6-A-2023-1
Version: 2

Updated

Jan 2026

Trousse SEER*Stat du Registre des cas de cancer de l’Ontario

La trousse SEER*Stat du Registre des cas de cancer de l’Ontario contient des fichiers de données anonymisées sur le cancer en Ontario extraits du...

Guidelines and Advice

Thoracic Surgical Oncology Standards

Status: In-Review
ID: 17-1
Version: 2

Mar 2015

Regimen

TORI(MNT)

Cancer Type:

Head and Neck,

Nasopharynx

Intent: Palliative

Drugs Used:

toripalimab (Unfunded)